Filing search / Day One Biopharmaceuticals, Inc. / "Death" / Page 2

424B5

b25ctcxxj162asv3dd

7 Jun 23

Prospectus supplement for primary offering

4:57pm

424B5

uawnhmysp2iabz

6 Jun 23

Prospectus supplement for primary offering

4:21pm

8-K

EX-99.1

wnts8odi6rqn

5 Jun 23

Regulation FD Disclosure

6:08am

8-K

EX-99.2

81viveogw8f

1 May 23

Day One Reports First Quarter 2023 Financial Results and Corporate Progress

9:01am

PRE 14A

9y06ajpn1z4q955t

18 Apr 23

Preliminary proxy

4:05pm

8-K

EX-99.2

n1o3dm

7 Nov 22

Day One Reports Third Quarter 2022 Financial Results and Corporate Progress

4:31pm

S-8

EX-99.1

guv53zag5d0

31 Oct 22

Registration of securities for employees

4:07pm

8-K

EX-99.2

qcz bpkm1fn

12 Sep 22

Day One Appoints Garry Nicholson as Chairman of the Board of Directors

8:40am

8-K

EX-99.2

mgtdbv1

4 Aug 22

Day One Reports Second Quarter 2022 Financial Results and Corporate Progress

4:53pm

8-K

EX-99.1

kl7nlnx fjqb0p2

24 Jun 22

Submission of Matters to a Vote of Security Holders

4:06pm

8-K

EX-1.1

i92iihl3o

16 Jun 22

Day One Announces Pricing of Upsized Public Offering of Common Stock

7:33am

424B5

8cbcf

16 Jun 22

Prospectus supplement for primary offering

7:30am

424B5

tiuey7gsmutrhw9vn7g

14 Jun 22

Prospectus supplement for primary offering

7:39am

8-K

EX-99.2

maa31

13 Jun 22

Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma

6:24am

8-K

EX-99.2

7tmm6pcw 0nehtyf

12 May 22

Day One Reports First Quarter 2022 Financial Results and Provides Business Update

4:33pm

DEF 14A

7ck er6owyfa0aw

28 Apr 22

Definitive proxy

4:44pm

8-K

EX-99.1

aqizjhu tfox

13 Apr 22

Targeted Therapies for People of All Ages April 2022

8:01am

10-K

EX-10.2

bwky mr98q1n30

7 Mar 22

Annual report

7:36am

10-K

cuxzxtnwalf0icgh

7 Mar 22

Annual report

7:36am